Comparative Pharmacology
Head-to-head clinical analysis: CLENZ LYTE versus SORBITOL 3 3 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLENZ LYTE versus SORBITOL 3 3 IN PLASTIC CONTAINER.
CLENZ-LYTE vs SORBITOL 3.3% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Colon lavage solution that osmotically induces diarrhea to cleanse the colon.
Sorbitol is a sugar alcohol that acts as an osmotic diuretic. It increases the osmolarity of the glomerular filtrate, which inhibits renal tubular reabsorption of water and electrolytes, thereby promoting diuresis. Additionally, it reduces intracranial pressure by creating an osmotic gradient that draws water from brain tissue into the cerebrospinal fluid and bloodstream.
Oral: 4 L (or 240 mL every 10 minutes) administered the evening before colonoscopy; alternatively, 2 L (or 240 mL every 10 minutes) plus 2 L of clear liquids given in split doses (first 1-2 L evening before, remaining in morning of procedure).
Intravenous infusion: 100-200 mL of a 3.3% solution (3.3-6.6 g sorbitol) over 15-30 minutes, typically used as an osmotic diuretic or for bowel preparation; frequency depends on indication, e.g., once for diagnostic procedures or up to 4 times daily for bowel evacuation.
None Documented
None Documented
Not applicable; systemic absorption is negligible (plasma levels below detection limits). Clinical effect is localized to gastrointestinal tract.
1.5–2.5 hours in normal renal function; prolonged in renal impairment (up to 20–30 hours in oliguric states).
Primarily fecal (approximately 95%) as unabsorbed polyethylene glycol; negligible renal excretion (<5%) as intact polymer.
Renal excretion of unchanged sorbitol; >90% eliminated via kidneys within 24 hours. Minor biliary/fecal elimination (<5%).
Category C
Category C
Laxative
Laxative